SQShane C. Quinonez

Shane C. Quinonez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shane C. Quinonez has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bridging the digital pathology divide: reciprocal learning between high-resource and low-resource settings

    by Kamran M Mirza, Arvind Rao, Jessica A Baker, Robert K Parker, Shane C Quinonez, Priscilla Njenga, Mansoor Saleh, Ulysses Gj Balis, Akbar K Waljee, Shahin Sayed

    Digital pathology (DP) represents a major advance in global health, integrating digital whole-slide imaging, telepathology and clinical-grade artificial intelligence into cohesive workflows that can improve diagnostic accuracy and educational access. Realising these gains, however, depends on local infrastructure, governance, reimbursement and workforce capacity. The COVID-19 pandemic accelerated DP uptake in some settings, but adoption remains highly uneven between high-resource settings (HRS) and low-resource settings (LRS), reflecting unequal infrastructure, workforce, policy and financing. This analysis contends that reciprocal innovation, a model of ongoing two-way learning between HRS and LRS that is distinct from one-way technology transfer, can accelerate DP adoption by leveraging the strengths of each environment. Drawing on examples from HRS and LRS, we examine use cases in education and clinical practice, the adoption barriers that persist and policy mechanisms required for sustainable scaling. While HRS contribute regulatory frameworks, validation standards and mentorship, LRS offer innovations in cost efficiency, workflow resilience and open-source adaptation that can inform more sustainable models globally. Neither HRS nor LRS are homogeneous entities. Resource availability also varies substantially within each category: HRS may contain poorly resourced institutions, while some institutions in LRS may have comparatively greater resources but still face broader system-level infrastructure constraints. Ensuring access to those in LRS requires targeted investment, harmonised standards and mutual learning across resource levels. DP has the potential to foster bidirectional partnerships to democratise access to timely, accurate and patient-centred pathology services across all resource settings.

  • Open Access

    Scaling global pathology education: insights from the Global Pathology and Laboratory Medicine Consortium (GPALMC) summit at University of Michigan

    by Kamran Mirza, Omar Z Baba, Marya Wahidi, Ulysses Balis, Lee Frederick Schroeder, Akbar K Waljee, Shane C Quinonez, Ghazi Zaatari, Manal Mahdy, Patricia Garcia, et al.

    Objectives To identify structural and systemic barriers to pathology education in low- and middle-income countries (LMICs), evaluate emerging digital and AI-driven solutions and develop consensus-based frameworks for sustainable diagnostic capacity building. Design Expert consensus-based synthesis. Qualitative synthesis of inaugural Global Pathology and Laboratory Medicine Consortium (GPALMC) summit proceedings using facilitated deliberative consensus, transcript-based thematic analysis with artificial intelligence (AI)-assisted synthesis and human oversight, triangulated with a scoping literature review. Setting University of Michigan, Ann Arbor, USA. Participants 20 multidisciplinary experts from eight countries spanning sub-Saharan Africa, North Africa, the Middle East, Latin America and North America, including pathologists, surgeons, public health officials and medical educators. Main outcome measures Identification of critical gaps in pathology training; refinement of the Residency in a Box cloud-based model with four LMIC-specific prerequisites, development of five interdependent strategic axes and policy recommendations on workforce retention, digital infrastructure and governance. Results Nearly 47% of the global population lacks access to essential diagnostics. Primary barriers include brain drain, infrastructure deficits and curricula misaligned with local disease burdens. Digital pathology and AI offer transformative potential but are hindered by high costs of ownership and a lack of diverse training datasets. Models from Ghana, Rwanda, India, Ethiopia and Nigeria confirm sustainable progress requires government ownership, phased implementation and integrated governance. Conclusions Scaling global pathology education requires a shift from donor-dependent aid towards nationally owned health system strengthening. The GPALMC framework integrates cloud-based training, bidirectional mentorship, contextualised curricula and diversified financing to close the diagnostic gap and advance health equity.

  • FGFR1:TACC1 ‐Fused Pilocytic Astrocytoma in a Child With Muenke Syndrome: A Case Report

    by Veda Malhotra, Andrew P. Lieberman, John R. Prensner, Shane C. Quinonez, Karin Muraszko, Neena I. Marupudi, Santhosh A. Upadhyaya

  • Open Access

    Medical genetics needs assessment: An online cross-sectional survey from Nepal

    by Pratiksha Gyawali, Binaya Shrestha, Kelly Beharry, Gareema Agarwal, Shane C. Quinonez

  • Open Access

    Genetics Evaluation Outcomes From an Academic Multidisciplinary Atypical Diabetes Program

    by Colby L Chase, Marie-Louise Accardo, Veronica Greve, Elizabeth G Ames, Shane C Quinonez, Anthony Scott, Lauren Hipp, Jenna Damon, Wendy R Uhlmann, David T Broome, et al.

    Context: Rare monogenic conditions that predispose to diabetes can be misdiagnosed due to phenotypic overlap with more common conditions. Misdiagnosis can lead to ineffective, over-, or under-treatment. Specific genetic mechanisms can direct more precise treatment and facilitate clinical trial options. Recognition of characteristics of these conditions is necessary to facilitate high-yield referrals to genetics providers in order to improve diagnosis and treatment. Objective: Highlight clinical characteristics and diagnostic outcomes of patients undergoing genetics evaluation through a multidisciplinary Atypical Diabetes Program. Design, Setting, and Patients: Retrospective cohort review was completed for 87 patients referred to genetics from endocrinologists associated with the multidisciplinary Atypical Diabetes Program at a tertiary academic medical center between September 2019 and October 2022. Main Outcome Measure: Description of clinical characteristics of patients with a diagnostic or uncertain clinical genetic test result, as well as proportion of patients with these results. Results: Six patients (8.8%) had a pathogenic variant confirming diagnosis of lipodystrophy (4), monogenic diabetes (1), or monogenic obesity (1). Fifteen (22.0%) had a variant of uncertain significance, 5 of which correlated with their clinical features. As a result of genetics evaluation, all with a confirmed diagnosis had more precise treatment implemented and/or the opportunity to enroll in a clinical trial. Conclusion: Identification of rare genetic conditions predisposing to diabetes, enabled here through multidisciplinary genetics and endocrinology collaboration as part of the Atypical Diabetes Program, ultimately improves patient care. Endocrinologist attention to clinical features of these conditions is key to inform referral for genetics evaluation and testing.


  • Open Access

    Implementation of a dedicated cascade testing clinic for patients at risk for hereditary cancer syndromes

    by Michelle F. Jacobs, Erika S. Koeppe, Colby L. Chase, Julia Martinez, Marie‐Louise Henry, Jenae M. Osborne, Elena M. Stoffel, Shane C. Quinonez

    Cascade testing, the site‐specific genetic testing of relatives within families with an inherited condition, is underutilized. Long wait times for appointments in specialty genetics clinics are a known barrier to genetic testing access. In our cancer genetics, New Patient Clinic (NPC), the long wait time for an appointment (on average 5 months for routine referrals), was identified by both providers and patients as a barrier to uptake of cascade testing. Timely testing of at‐risk relatives is essential to maximize the benefits of cascade testing and reduce cancer morbidity and mortality. Our objective was to improve access via implementation of a different clinical model that designated appointments for patients seeking cascade testing. A secondary goal was to improve use of genetic counselor time. We implemented a dedicated Cascade Testing Clinic (CTC) with an expedited triaging and unique scheduling model to decrease patient wait time to appointment and optimize clinician time. We report on the process and outcomes here. Between October 2016 and February 2020, the average wait time between referral date and first scheduled appointment date was 46 days for the CTC compared to 144 days for the NPC (p < 0.0001). No‐show/cancelation/rescheduling rate was 11.7% in the CTC compared to 29.7% in the NPC (p < 0.0001). Genetic counselors saw approximately twice as many patients per half‐day clinic in the CTC compared to the NPC (p < 0.00001). Modifications to clinic staffing and appointment times were made based on provider feedback. Implementation of a dedicated clinic specifically for patients seeking cascade testing significantly shortened wait times for this population, reduced patient drop‐off, and improved clinician efficiency. The relatively straightforward indications and generally uncomplicated medical histories made this an ideal population for expedited appointments.


  • Open Access

    The introduction of genetic counseling in Ethiopia: Results of a training workshop and lessons learned

    by Shane C. Quinonez, Bridget C. O’cOnnor, Michelle F. Jacobs, Atnafu Mekonnen Tekleab, Ayalew Marye, Delayehu Bekele, Beverly M. Yashar, Erika Hanson, Abate Yeshidinber, Getahun Wedaje

    Background: Over the past two decades non-communicable diseases (NCDs) have steadily increased as a cause of worldwide disability and mortality with a concomitant decrease in disease burden from communicable, maternal, neonatal and nutritional conditions. Congenital anomalies, the most common NCD affecting children, have recently become the fifth leading cause of under-five mortality worldwide, ahead of other conditions such as malaria, neonatal sepsis and malnutrition. Genetic counseling has been shown to be an effective method to decrease the impact of congenital anomalies and genetic conditions but is absent in almost all sub-Saharan Africa countries. To address this need for counseling services we designed and implemented the first broad-based genetic counseling curriculum in Ethiopia, launching it at St. Paul’s Millennium Medical College (SPHMMC) in Addis Ababa, Ethiopia.Methods: The curriculum, created by Michigan Medicine and SPHMMC specialists, consisted of medical knowledge and genetic counseling content and was delivered to two cohorts of nurses. Curriculum evaluation consisted of satisfaction surveys and pre- and post-assessments covering medical knowledge and genetic counseling content. Following Cohort 1 training, the curriculum was modified to increase the medical knowledge material and decrease Western genetic counseling principles material.Results: Both cohorts reported high levels of satisfaction but felt the workshop was too short. No significant improvements in assessment scores were seen for Cohort 1 in terms of total scores and medical knowledge and genetic counseling-specific questions. Following curriculum modification, improvements were seen in Cohort 2 with an increase in total assessment scores from 63% to 73% (p = 0.043), with medical knowledge-specific questions increasing from 57% to 79% (p = 0.01) with no significant change in genetic counseling-specific scores. Multiple logistic, financial, cultural and systems-specific barriers were identified with recommendations for their consideration presented.Conclusion: Genetics medical knowledge of Ethiopian nurses increased significantly following curriculum delivery though difficulty was encountered with Western genetic counseling material.


  • The introduction of clinical genetic testing in Ethiopia: Experiences and lessons learned

    by Shane C. Quinonez, Zewdu Terefework

    Limited data are available on genetic testing laboratories in low‐ and middle‐income countries including those in sub‐Saharan Africa (SSA). To characterize the need for genetic testing in SSA we describe the experience of MRC‐ET Advanced Laboratory, a genetic testing laboratory in Ethiopia. Test results were analyzed based on indication(s) for testing, referral category, and diagnostic yield. A total of 1311 tests were run using the full MRC‐Holland catalogue of Multiplex‐Ligation Probe Amplification assays. Of all samples, 77% were postnatal samples, 15% products of conception (POC), and 8% amniotic samples. Of postnatal samples, the most common testing categories were multiple congenital anomalies (32%), disorders of sex development (17%), and Obstetrics/Gynecology (16%). Forty‐three percent of postnatal samples were diagnostic, 11% were variants of uncertain significance (VUS), and 46% were normal with Trisomy 21 the most common diagnosis. Of POC samples, 10% were diagnostic, 34% revealed VUSs, and 55% were normal with Trisomy 18 the most common diagnosis. Of amniotic samples 17.5% were diagnostic, 3% revealed VUSs, and 79% were normal with Trisomy 18 the most common diagnosis. There is increasing demand for genetic testing in Ethiopia. Diagnostic genetic testing in SSA deserves increased attention as testing platforms become more affordable.


  • Trainee perspectives of COVID-19 impact on medical genetics education

    by Amanda Barone Pritchard, Christina Sloan-Heggen, Catherine E. Keegan, Shane C. Quinonez